nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—MPO—atherosclerosis	0.634	1	CbGaD
Cysteamine—MPO—superior mesenteric artery—atherosclerosis	0.0388	0.362	CbGeAlD
Cysteamine—SST—vein—atherosclerosis	0.0253	0.236	CbGeAlD
Cysteamine—SST—artery—atherosclerosis	0.0103	0.0961	CbGeAlD
Cysteamine—SST—blood vessel—atherosclerosis	0.00803	0.0749	CbGeAlD
Cysteamine—MPO—artery—atherosclerosis	0.00415	0.0387	CbGeAlD
Cysteamine—SST—connective tissue—atherosclerosis	0.00412	0.0384	CbGeAlD
Cysteamine—SST—cardiovascular system—atherosclerosis	0.00358	0.0334	CbGeAlD
Cysteamine—MPO—endothelium—atherosclerosis	0.00351	0.0327	CbGeAlD
Cysteamine—Leg pain—Lovastatin—atherosclerosis	0.00326	0.0315	CcSEcCtD
Cysteamine—MPO—blood vessel—atherosclerosis	0.00323	0.0301	CbGeAlD
Cysteamine—SST—liver—atherosclerosis	0.00222	0.0207	CbGeAlD
Cysteamine—Redness—Niacin—atherosclerosis	0.00191	0.0185	CcSEcCtD
Cysteamine—Nightmare—Rosuvastatin—atherosclerosis	0.00171	0.0166	CcSEcCtD
Cysteamine—MPO—connective tissue—atherosclerosis	0.00166	0.0155	CbGeAlD
Cysteamine—Bone disorder—Ezetimibe—atherosclerosis	0.00163	0.0158	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Lovastatin—atherosclerosis	0.0015	0.0146	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Ezetimibe—atherosclerosis	0.00147	0.0143	CcSEcCtD
Cysteamine—Gastroenteritis—Rosuvastatin—atherosclerosis	0.00145	0.0141	CcSEcCtD
Cysteamine—MPO—cardiovascular system—atherosclerosis	0.00144	0.0134	CbGeAlD
Cysteamine—Bone disorder—Niacin—atherosclerosis	0.00143	0.0138	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Simvastatin—atherosclerosis	0.00141	0.0136	CcSEcCtD
Cysteamine—Nightmare—Simvastatin—atherosclerosis	0.00136	0.0132	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Pravastatin—atherosclerosis	0.00127	0.0123	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.00125	0.0122	CcSEcCtD
Cysteamine—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00125	0.0121	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.00123	0.0119	CcSEcCtD
Cysteamine—Nightmare—Pravastatin—atherosclerosis	0.00123	0.0119	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.00117	0.0114	CcSEcCtD
Cysteamine—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00117	0.0113	CcSEcCtD
Cysteamine—Pain in extremity—Lovastatin—atherosclerosis	0.00109	0.0106	CcSEcCtD
Cysteamine—Hepatic function abnormal—Niacin—atherosclerosis	0.00107	0.0104	CcSEcCtD
Cysteamine—Pain in extremity—Ezetimibe—atherosclerosis	0.00107	0.0104	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.00106	0.0103	CcSEcCtD
Cysteamine—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00106	0.0102	CcSEcCtD
Cysteamine—Liver function test abnormal—Ezetimibe—atherosclerosis	0.000988	0.00957	CcSEcCtD
Cysteamine—Affect lability—Pravastatin—atherosclerosis	0.000908	0.0088	CcSEcCtD
Cysteamine—MPO—liver—atherosclerosis	0.000892	0.00832	CbGeAlD
Cysteamine—Mood swings—Pravastatin—atherosclerosis	0.000874	0.00847	CcSEcCtD
Cysteamine—Liver function test abnormal—Niacin—atherosclerosis	0.000865	0.00838	CcSEcCtD
Cysteamine—Liver function test abnormal—Pravastatin—atherosclerosis	0.000852	0.00825	CcSEcCtD
Cysteamine—Mental disorder—Rosuvastatin—atherosclerosis	0.00078	0.00756	CcSEcCtD
Cysteamine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000728	0.00705	CcSEcCtD
Cysteamine—Immune system disorder—Ezetimibe—atherosclerosis	0.000669	0.00648	CcSEcCtD
Cysteamine—Mental disorder—Ezetimibe—atherosclerosis	0.000649	0.00628	CcSEcCtD
Cysteamine—Malnutrition—Ezetimibe—atherosclerosis	0.000644	0.00624	CcSEcCtD
Cysteamine—Erythema—Ezetimibe—atherosclerosis	0.000644	0.00624	CcSEcCtD
Cysteamine—Confusional state—Rosuvastatin—atherosclerosis	0.000638	0.00618	CcSEcCtD
Cysteamine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000621	0.00601	CcSEcCtD
Cysteamine—Mental disorder—Simvastatin—atherosclerosis	0.000619	0.00599	CcSEcCtD
Cysteamine—Tremor—Lovastatin—atherosclerosis	0.000616	0.00596	CcSEcCtD
Cysteamine—Erythema—Simvastatin—atherosclerosis	0.000615	0.00595	CcSEcCtD
Cysteamine—Anaemia—Ezetimibe—atherosclerosis	0.000596	0.00577	CcSEcCtD
Cysteamine—Leukopenia—Lovastatin—atherosclerosis	0.000588	0.0057	CcSEcCtD
Cysteamine—Tremor—Simvastatin—atherosclerosis	0.000576	0.00558	CcSEcCtD
Cysteamine—Anaemia—Simvastatin—atherosclerosis	0.000568	0.0055	CcSEcCtD
Cysteamine—Malnutrition—Niacin—atherosclerosis	0.000564	0.00547	CcSEcCtD
Cysteamine—Erythema—Niacin—atherosclerosis	0.000564	0.00547	CcSEcCtD
Cysteamine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000557	0.0054	CcSEcCtD
Cysteamine—Hypertension—Ezetimibe—atherosclerosis	0.000556	0.00539	CcSEcCtD
Cysteamine—Tension—Niacin—atherosclerosis	0.000554	0.00537	CcSEcCtD
Cysteamine—Discomfort—Lovastatin—atherosclerosis	0.000553	0.00535	CcSEcCtD
Cysteamine—Leukopenia—Simvastatin—atherosclerosis	0.00055	0.00533	CcSEcCtD
Cysteamine—Nervousness—Niacin—atherosclerosis	0.000548	0.00531	CcSEcCtD
Cysteamine—Tension—Pravastatin—atherosclerosis	0.000545	0.00528	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000545	0.00528	CcSEcCtD
Cysteamine—Discomfort—Ezetimibe—atherosclerosis	0.000542	0.00525	CcSEcCtD
Cysteamine—Constipation—Rosuvastatin—atherosclerosis	0.000541	0.00524	CcSEcCtD
Cysteamine—Confusional state—Lovastatin—atherosclerosis	0.000541	0.00524	CcSEcCtD
Cysteamine—Nervousness—Pravastatin—atherosclerosis	0.00054	0.00523	CcSEcCtD
Cysteamine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000536	0.0052	CcSEcCtD
Cysteamine—Confusional state—Ezetimibe—atherosclerosis	0.00053	0.00514	CcSEcCtD
Cysteamine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000526	0.0051	CcSEcCtD
Cysteamine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000521	0.00505	CcSEcCtD
Cysteamine—Tremor—Pravastatin—atherosclerosis	0.000521	0.00504	CcSEcCtD
Cysteamine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000517	0.00501	CcSEcCtD
Cysteamine—Discomfort—Simvastatin—atherosclerosis	0.000517	0.00501	CcSEcCtD
Cysteamine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000516	0.005	CcSEcCtD
Cysteamine—Anaemia—Pravastatin—atherosclerosis	0.000514	0.00498	CcSEcCtD
Cysteamine—Anorexia—Lovastatin—atherosclerosis	0.000511	0.00495	CcSEcCtD
Cysteamine—Skin disorder—Ezetimibe—atherosclerosis	0.000511	0.00495	CcSEcCtD
Cysteamine—Confusional state—Simvastatin—atherosclerosis	0.000506	0.0049	CcSEcCtD
Cysteamine—Leukopenia—Niacin—atherosclerosis	0.000505	0.00489	CcSEcCtD
Cysteamine—Urticaria—Rosuvastatin—atherosclerosis	0.000503	0.00487	CcSEcCtD
Cysteamine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000502	0.00486	CcSEcCtD
Cysteamine—Abdominal pain—Rosuvastatin—atherosclerosis	0.0005	0.00485	CcSEcCtD
Cysteamine—Leukopenia—Pravastatin—atherosclerosis	0.000497	0.00482	CcSEcCtD
Cysteamine—Hypertension—Pravastatin—atherosclerosis	0.00048	0.00465	CcSEcCtD
Cysteamine—Anorexia—Simvastatin—atherosclerosis	0.000478	0.00463	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000477	0.00462	CcSEcCtD
Cysteamine—Dyspepsia—Lovastatin—atherosclerosis	0.000472	0.00457	CcSEcCtD
Cysteamine—Discomfort—Pravastatin—atherosclerosis	0.000467	0.00453	CcSEcCtD
Cysteamine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000466	0.00452	CcSEcCtD
Cysteamine—Decreased appetite—Lovastatin—atherosclerosis	0.000466	0.00452	CcSEcCtD
Cysteamine—Dyspepsia—Ezetimibe—atherosclerosis	0.000463	0.00449	CcSEcCtD
Cysteamine—Fatigue—Lovastatin—atherosclerosis	0.000462	0.00448	CcSEcCtD
Cysteamine—Anaphylactic shock—Niacin—atherosclerosis	0.000461	0.00446	CcSEcCtD
Cysteamine—Constipation—Lovastatin—atherosclerosis	0.000459	0.00444	CcSEcCtD
Cysteamine—Confusional state—Pravastatin—atherosclerosis	0.000457	0.00443	CcSEcCtD
Cysteamine—Decreased appetite—Ezetimibe—atherosclerosis	0.000457	0.00443	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000454	0.0044	CcSEcCtD
Cysteamine—Asthenia—Rosuvastatin—atherosclerosis	0.000454	0.0044	CcSEcCtD
Cysteamine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000453	0.00439	CcSEcCtD
Cysteamine—Fatigue—Ezetimibe—atherosclerosis	0.000453	0.00439	CcSEcCtD
Cysteamine—Constipation—Ezetimibe—atherosclerosis	0.00045	0.00436	CcSEcCtD
Cysteamine—Skin disorder—Niacin—atherosclerosis	0.000447	0.00433	CcSEcCtD
Cysteamine—Feeling abnormal—Lovastatin—atherosclerosis	0.000442	0.00428	CcSEcCtD
Cysteamine—Dyspepsia—Simvastatin—atherosclerosis	0.000442	0.00428	CcSEcCtD
Cysteamine—Anorexia—Niacin—atherosclerosis	0.000439	0.00425	CcSEcCtD
Cysteamine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000439	0.00425	CcSEcCtD
Cysteamine—Decreased appetite—Simvastatin—atherosclerosis	0.000436	0.00422	CcSEcCtD
Cysteamine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000433	0.0042	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000433	0.0042	CcSEcCtD
Cysteamine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000433	0.00419	CcSEcCtD
Cysteamine—Fatigue—Simvastatin—atherosclerosis	0.000432	0.00419	CcSEcCtD
Cysteamine—Anorexia—Pravastatin—atherosclerosis	0.000432	0.00419	CcSEcCtD
Cysteamine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00043	0.00417	CcSEcCtD
Cysteamine—Constipation—Simvastatin—atherosclerosis	0.000429	0.00416	CcSEcCtD
Cysteamine—Urticaria—Lovastatin—atherosclerosis	0.000426	0.00413	CcSEcCtD
Cysteamine—Body temperature increased—Lovastatin—atherosclerosis	0.000424	0.00411	CcSEcCtD
Cysteamine—Abdominal pain—Lovastatin—atherosclerosis	0.000424	0.00411	CcSEcCtD
Cysteamine—Dizziness—Rosuvastatin—atherosclerosis	0.000418	0.00405	CcSEcCtD
Cysteamine—Urticaria—Ezetimibe—atherosclerosis	0.000418	0.00405	CcSEcCtD
Cysteamine—Body temperature increased—Ezetimibe—atherosclerosis	0.000416	0.00403	CcSEcCtD
Cysteamine—Abdominal pain—Ezetimibe—atherosclerosis	0.000416	0.00403	CcSEcCtD
Cysteamine—Feeling abnormal—Simvastatin—atherosclerosis	0.000413	0.004	CcSEcCtD
Cysteamine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00041	0.00397	CcSEcCtD
Cysteamine—Somnolence—Niacin—atherosclerosis	0.000409	0.00397	CcSEcCtD
Cysteamine—Dyspepsia—Niacin—atherosclerosis	0.000405	0.00393	CcSEcCtD
Cysteamine—Decreased appetite—Niacin—atherosclerosis	0.0004	0.00388	CcSEcCtD
Cysteamine—Dyspepsia—Pravastatin—atherosclerosis	0.000399	0.00387	CcSEcCtD
Cysteamine—Rash—Rosuvastatin—atherosclerosis	0.000399	0.00387	CcSEcCtD
Cysteamine—Dermatitis—Rosuvastatin—atherosclerosis	0.000399	0.00386	CcSEcCtD
Cysteamine—Urticaria—Simvastatin—atherosclerosis	0.000398	0.00386	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000398	0.00385	CcSEcCtD
Cysteamine—Abdominal pain—Simvastatin—atherosclerosis	0.000397	0.00384	CcSEcCtD
Cysteamine—Body temperature increased—Simvastatin—atherosclerosis	0.000397	0.00384	CcSEcCtD
Cysteamine—Headache—Rosuvastatin—atherosclerosis	0.000396	0.00384	CcSEcCtD
Cysteamine—Hypersensitivity—Lovastatin—atherosclerosis	0.000395	0.00383	CcSEcCtD
Cysteamine—Decreased appetite—Pravastatin—atherosclerosis	0.000394	0.00382	CcSEcCtD
Cysteamine—Fatigue—Pravastatin—atherosclerosis	0.000391	0.00379	CcSEcCtD
Cysteamine—Constipation—Pravastatin—atherosclerosis	0.000388	0.00376	CcSEcCtD
Cysteamine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000388	0.00375	CcSEcCtD
Cysteamine—Asthenia—Lovastatin—atherosclerosis	0.000385	0.00373	CcSEcCtD
Cysteamine—Asthenia—Ezetimibe—atherosclerosis	0.000377	0.00366	CcSEcCtD
Cysteamine—Gastrointestinal pain—Niacin—atherosclerosis	0.000377	0.00365	CcSEcCtD
Cysteamine—Nausea—Rosuvastatin—atherosclerosis	0.000376	0.00364	CcSEcCtD
Cysteamine—Feeling abnormal—Pravastatin—atherosclerosis	0.000374	0.00362	CcSEcCtD
Cysteamine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000371	0.00359	CcSEcCtD
Cysteamine—Hypersensitivity—Simvastatin—atherosclerosis	0.00037	0.00358	CcSEcCtD
Cysteamine—Diarrhoea—Lovastatin—atherosclerosis	0.000367	0.00355	CcSEcCtD
Cysteamine—Urticaria—Niacin—atherosclerosis	0.000366	0.00354	CcSEcCtD
Cysteamine—Abdominal pain—Niacin—atherosclerosis	0.000364	0.00353	CcSEcCtD
Cysteamine—Body temperature increased—Niacin—atherosclerosis	0.000364	0.00353	CcSEcCtD
Cysteamine—Urticaria—Pravastatin—atherosclerosis	0.00036	0.00349	CcSEcCtD
Cysteamine—Asthenia—Simvastatin—atherosclerosis	0.00036	0.00349	CcSEcCtD
Cysteamine—Diarrhoea—Ezetimibe—atherosclerosis	0.00036	0.00349	CcSEcCtD
Cysteamine—Abdominal pain—Pravastatin—atherosclerosis	0.000358	0.00347	CcSEcCtD
Cysteamine—Body temperature increased—Pravastatin—atherosclerosis	0.000358	0.00347	CcSEcCtD
Cysteamine—Dizziness—Lovastatin—atherosclerosis	0.000355	0.00344	CcSEcCtD
Cysteamine—Dizziness—Ezetimibe—atherosclerosis	0.000348	0.00337	CcSEcCtD
Cysteamine—Diarrhoea—Simvastatin—atherosclerosis	0.000343	0.00333	CcSEcCtD
Cysteamine—Vomiting—Lovastatin—atherosclerosis	0.000341	0.0033	CcSEcCtD
Cysteamine—Hypersensitivity—Niacin—atherosclerosis	0.000339	0.00329	CcSEcCtD
Cysteamine—Rash—Lovastatin—atherosclerosis	0.000338	0.00328	CcSEcCtD
Cysteamine—Dermatitis—Lovastatin—atherosclerosis	0.000338	0.00327	CcSEcCtD
Cysteamine—Headache—Lovastatin—atherosclerosis	0.000336	0.00325	CcSEcCtD
Cysteamine—Vomiting—Ezetimibe—atherosclerosis	0.000334	0.00324	CcSEcCtD
Cysteamine—Hypersensitivity—Pravastatin—atherosclerosis	0.000334	0.00324	CcSEcCtD
Cysteamine—Dizziness—Simvastatin—atherosclerosis	0.000332	0.00321	CcSEcCtD
Cysteamine—Rash—Ezetimibe—atherosclerosis	0.000332	0.00321	CcSEcCtD
Cysteamine—Dermatitis—Ezetimibe—atherosclerosis	0.000331	0.00321	CcSEcCtD
Cysteamine—Asthenia—Niacin—atherosclerosis	0.00033	0.0032	CcSEcCtD
Cysteamine—Headache—Ezetimibe—atherosclerosis	0.00033	0.00319	CcSEcCtD
Cysteamine—Asthenia—Pravastatin—atherosclerosis	0.000325	0.00315	CcSEcCtD
Cysteamine—MPO—Vitamin B12 Metabolism—IL1B—atherosclerosis	0.000321	0.00206	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—ALB—atherosclerosis	0.000321	0.00206	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCL4—atherosclerosis	0.00032	0.00205	CbGpPWpGaD
Cysteamine—Vomiting—Simvastatin—atherosclerosis	0.000319	0.00309	CcSEcCtD
Cysteamine—Nausea—Lovastatin—atherosclerosis	0.000319	0.00309	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—SERPINE1—atherosclerosis	0.000318	0.00204	CbGpPWpGaD
Cysteamine—Rash—Simvastatin—atherosclerosis	0.000316	0.00306	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—KNG1—atherosclerosis	0.000316	0.00203	CbGpPWpGaD
Cysteamine—Dermatitis—Simvastatin—atherosclerosis	0.000316	0.00306	CcSEcCtD
Cysteamine—Diarrhoea—Niacin—atherosclerosis	0.000315	0.00305	CcSEcCtD
Cysteamine—Headache—Simvastatin—atherosclerosis	0.000314	0.00304	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—UTS2—atherosclerosis	0.000314	0.00202	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—AGTR1—atherosclerosis	0.000314	0.00202	CbGpPWpGaD
Cysteamine—Nausea—Ezetimibe—atherosclerosis	0.000312	0.00303	CcSEcCtD
Cysteamine—Diarrhoea—Pravastatin—atherosclerosis	0.00031	0.00301	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000308	0.00198	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—F2—atherosclerosis	0.000307	0.00197	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL4—atherosclerosis	0.000307	0.00197	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—ICAM1—atherosclerosis	0.000306	0.00196	CbGpPWpGaD
Cysteamine—Dizziness—Niacin—atherosclerosis	0.000305	0.00295	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000303	0.00194	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—TNF—atherosclerosis	0.000302	0.00193	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—UTS2—atherosclerosis	0.000301	0.00193	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CASR—atherosclerosis	0.000301	0.00193	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—NFKB1—atherosclerosis	0.0003	0.00192	CbGpPWpGaD
Cysteamine—Dizziness—Pravastatin—atherosclerosis	0.0003	0.00291	CcSEcCtD
Cysteamine—Nausea—Simvastatin—atherosclerosis	0.000298	0.00289	CcSEcCtD
Cysteamine—SST—Peptide ligand-binding receptors—CXCL8—atherosclerosis	0.000294	0.00189	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IFNG—atherosclerosis	0.000293	0.00188	CbGpPWpGaD
Cysteamine—Vomiting—Niacin—atherosclerosis	0.000293	0.00284	CcSEcCtD
Cysteamine—Rash—Niacin—atherosclerosis	0.00029	0.00281	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.00029	0.00186	CbGpPWpGaD
Cysteamine—Dermatitis—Niacin—atherosclerosis	0.00029	0.00281	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CASR—atherosclerosis	0.000289	0.00185	CbGpPWpGaD
Cysteamine—Headache—Niacin—atherosclerosis	0.000289	0.0028	CcSEcCtD
Cysteamine—Vomiting—Pravastatin—atherosclerosis	0.000288	0.00279	CcSEcCtD
Cysteamine—Rash—Pravastatin—atherosclerosis	0.000286	0.00277	CcSEcCtD
Cysteamine—Dermatitis—Pravastatin—atherosclerosis	0.000286	0.00277	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—UTS2—atherosclerosis	0.000285	0.00183	CbGpPWpGaD
Cysteamine—Headache—Pravastatin—atherosclerosis	0.000284	0.00275	CcSEcCtD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CXCL8—atherosclerosis	0.000282	0.00181	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CNR2—atherosclerosis	0.00028	0.0018	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.00028	0.00179	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.00028	0.00179	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—INS—atherosclerosis	0.000278	0.00179	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—EDN1—atherosclerosis	0.000278	0.00178	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL5—atherosclerosis	0.000276	0.00177	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—CCL2—atherosclerosis	0.000274	0.00176	CbGpPWpGaD
Cysteamine—Nausea—Niacin—atherosclerosis	0.000274	0.00265	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CX3CR1—atherosclerosis	0.000274	0.00175	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CASR—atherosclerosis	0.000274	0.00175	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—UTS2—atherosclerosis	0.000274	0.00175	CbGpPWpGaD
Cysteamine—Nausea—Pravastatin—atherosclerosis	0.000269	0.00261	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CNR2—atherosclerosis	0.000269	0.00172	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CX3CL1—atherosclerosis	0.000268	0.00172	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000268	0.00172	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—EDN1—atherosclerosis	0.000266	0.00171	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCL5—atherosclerosis	0.000264	0.0017	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CX3CR1—atherosclerosis	0.000262	0.00168	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CASR—atherosclerosis	0.000262	0.00168	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HRH1—atherosclerosis	0.000262	0.00168	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL1B—atherosclerosis	0.000262	0.00168	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CX3CL1—atherosclerosis	0.000257	0.00165	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—SERPINE1—atherosclerosis	0.000256	0.00164	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—ALB—atherosclerosis	0.000255	0.00164	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CNR2—atherosclerosis	0.000254	0.00163	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HRH1—atherosclerosis	0.000251	0.00161	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000249	0.0016	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CXCL8—atherosclerosis	0.000248	0.00159	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—NFKB1—atherosclerosis	0.000244	0.00157	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CNR2—atherosclerosis	0.000244	0.00156	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL6—atherosclerosis	0.000243	0.00156	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.00024	0.00154	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000239	0.00153	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCL8—atherosclerosis	0.000238	0.00153	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—MAPK8—atherosclerosis	0.000237	0.00152	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—TNF—atherosclerosis	0.000233	0.0015	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IFNG—atherosclerosis	0.000233	0.00149	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—PTGS2—atherosclerosis	0.000232	0.00149	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—AGT—atherosclerosis	0.000231	0.00148	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—PTGS2—atherosclerosis	0.000223	0.00143	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—AGT—atherosclerosis	0.000221	0.00142	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCL3—atherosclerosis	0.000219	0.0014	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—EDNRA—atherosclerosis	0.000218	0.0014	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CCR2—atherosclerosis	0.000218	0.0014	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—F2—atherosclerosis	0.000213	0.00137	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—GHRL—atherosclerosis	0.000212	0.00136	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL3—atherosclerosis	0.00021	0.00135	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CCR2—atherosclerosis	0.000209	0.00134	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—EDNRA—atherosclerosis	0.000209	0.00134	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IL1B—atherosclerosis	0.000208	0.00133	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APOA4—atherosclerosis	0.000205	0.00132	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—F2—atherosclerosis	0.000204	0.00131	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—GHRL—atherosclerosis	0.000203	0.00131	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCR2—atherosclerosis	0.000198	0.00127	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EDNRA—atherosclerosis	0.000198	0.00127	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000197	0.00126	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APOA4—atherosclerosis	0.000197	0.00126	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—NFKB1—atherosclerosis	0.000194	0.00124	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000193	0.00124	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—GHRL—atherosclerosis	0.000193	0.00124	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL2—atherosclerosis	0.00019	0.00122	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TNF—atherosclerosis	0.00019	0.00122	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCR2—atherosclerosis	0.00019	0.00122	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EDNRA—atherosclerosis	0.00019	0.00122	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL4—atherosclerosis	0.000189	0.00121	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000189	0.00121	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—atherosclerosis	0.000188	0.00121	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—KNG1—atherosclerosis	0.000186	0.0012	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AGTR1—atherosclerosis	0.000185	0.00119	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—GHRL—atherosclerosis	0.000185	0.00119	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCL2—atherosclerosis	0.000182	0.00117	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL4—atherosclerosis	0.000181	0.00116	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—KNG1—atherosclerosis	0.000179	0.00115	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AGTR1—atherosclerosis	0.000178	0.00114	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APOA2—atherosclerosis	0.000177	0.00113	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APOA2—atherosclerosis	0.000169	0.00109	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—KNG1—atherosclerosis	0.000169	0.00109	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—UTS2—atherosclerosis	0.000169	0.00108	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AGTR1—atherosclerosis	0.000168	0.00108	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—KNG1—atherosclerosis	0.000162	0.00104	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CX3CR1—atherosclerosis	0.000162	0.00104	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CASR—atherosclerosis	0.000162	0.00104	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—UTS2—atherosclerosis	0.000162	0.00104	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AGTR1—atherosclerosis	0.000161	0.00103	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CX3CL1—atherosclerosis	0.000158	0.00102	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—EDN1—atherosclerosis	0.000157	0.00101	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CCL5—atherosclerosis	0.000156	0.000999	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CX3CR1—atherosclerosis	0.000155	0.000994	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CASR—atherosclerosis	0.000155	0.000994	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL6—atherosclerosis	0.000153	0.000983	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CX3CL1—atherosclerosis	0.000152	0.000975	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—atherosclerosis	0.000151	0.000971	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—TNF—atherosclerosis	0.000151	0.000967	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—EDN1—atherosclerosis	0.000151	0.000966	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CNR2—atherosclerosis	0.00015	0.000964	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCL8—atherosclerosis	0.00015	0.000963	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MMP3—atherosclerosis	0.00015	0.000962	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CCL5—atherosclerosis	0.000149	0.000958	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PRKCG—atherosclerosis	0.000148	0.00095	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CNR2—atherosclerosis	0.000144	0.000924	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCL8—atherosclerosis	0.000144	0.000923	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MMP3—atherosclerosis	0.000144	0.000922	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EDN1—atherosclerosis	0.000143	0.000915	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PRKCG—atherosclerosis	0.000142	0.000911	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCL5—atherosclerosis	0.000141	0.000907	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EDN1—atherosclerosis	0.000137	0.000877	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL5—atherosclerosis	0.000136	0.00087	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PRKCG—atherosclerosis	0.000134	0.000863	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VWF—atherosclerosis	0.000134	0.000859	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APOC3—atherosclerosis	0.000133	0.000854	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—LDLR—atherosclerosis	0.000132	0.000848	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AGT—atherosclerosis	0.00013	0.000836	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL3—atherosclerosis	0.000129	0.000829	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PRKCG—atherosclerosis	0.000129	0.000827	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VWF—atherosclerosis	0.000128	0.000824	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APOC3—atherosclerosis	0.000128	0.000818	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LDLR—atherosclerosis	0.000127	0.000813	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AGT—atherosclerosis	0.000125	0.000801	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL3—atherosclerosis	0.000124	0.000795	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NCF1—atherosclerosis	0.000124	0.000794	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—atherosclerosis	0.000122	0.000781	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—F2—atherosclerosis	0.00012	0.000772	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NCF1—atherosclerosis	0.000119	0.000761	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AGT—atherosclerosis	0.000118	0.000759	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EDNRA—atherosclerosis	0.000117	0.000749	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCR2—atherosclerosis	0.000117	0.000749	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CYBA—atherosclerosis	0.000116	0.000746	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—F2—atherosclerosis	0.000115	0.000741	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000115	0.000739	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PLAT—atherosclerosis	0.000114	0.00073	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PARP1—atherosclerosis	0.000114	0.00073	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GHRL—atherosclerosis	0.000114	0.00073	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AGT—atherosclerosis	0.000113	0.000728	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EDNRA—atherosclerosis	0.000112	0.000719	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCR2—atherosclerosis	0.000112	0.000719	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CYBA—atherosclerosis	0.000112	0.000715	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CG—atherosclerosis	0.00011	0.000709	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—F2—atherosclerosis	0.000109	0.000701	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GHRL—atherosclerosis	0.000109	0.0007	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PARP1—atherosclerosis	0.000109	0.0007	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PLAT—atherosclerosis	0.000109	0.0007	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—F2—atherosclerosis	0.000105	0.000672	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CG—atherosclerosis	0.000105	0.000671	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CG—atherosclerosis	0.0001	0.000644	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KNG1—atherosclerosis	9.99e-05	0.000641	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AGTR1—atherosclerosis	9.93e-05	0.000637	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCL2—atherosclerosis	9.75e-05	0.000625	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PLG—atherosclerosis	9.68e-05	0.000621	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KNG1—atherosclerosis	9.58e-05	0.000615	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AGTR1—atherosclerosis	9.52e-05	0.000611	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL2—atherosclerosis	9.34e-05	0.000599	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PLG—atherosclerosis	9.28e-05	0.000595	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SOCS3—atherosclerosis	9.17e-05	0.000588	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MMP3—atherosclerosis	8.85e-05	0.000568	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IGF2—atherosclerosis	8.82e-05	0.000565	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SOCS3—atherosclerosis	8.79e-05	0.000564	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APOB—atherosclerosis	8.56e-05	0.000549	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MMP3—atherosclerosis	8.49e-05	0.000545	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CXCL8—atherosclerosis	8.49e-05	0.000544	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF2—atherosclerosis	8.45e-05	0.000542	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EDN1—atherosclerosis	8.42e-05	0.00054	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL5—atherosclerosis	8.36e-05	0.000536	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APOB—atherosclerosis	8.2e-05	0.000526	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—LPL—atherosclerosis	8.17e-05	0.000524	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL8—atherosclerosis	8.14e-05	0.000522	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EDN1—atherosclerosis	8.07e-05	0.000518	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL5—atherosclerosis	8.01e-05	0.000514	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PRKCG—atherosclerosis	7.95e-05	0.00051	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LPL—atherosclerosis	7.83e-05	0.000503	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SPP1—atherosclerosis	7.74e-05	0.000496	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CXCL8—atherosclerosis	7.71e-05	0.000494	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PRKCG—atherosclerosis	7.62e-05	0.000489	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SPP1—atherosclerosis	7.42e-05	0.000476	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CXCL8—atherosclerosis	7.39e-05	0.000474	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PDGFB—atherosclerosis	7.16e-05	0.000459	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AGT—atherosclerosis	6.99e-05	0.000448	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PDGFB—atherosclerosis	6.87e-05	0.00044	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—LEP—atherosclerosis	6.85e-05	0.000439	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APOE—atherosclerosis	6.85e-05	0.000439	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CAV1—atherosclerosis	6.79e-05	0.000435	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APOA1—atherosclerosis	6.77e-05	0.000434	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AGT—atherosclerosis	6.7e-05	0.00043	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LEP—atherosclerosis	6.57e-05	0.000421	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APOE—atherosclerosis	6.57e-05	0.000421	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ESR1—atherosclerosis	6.54e-05	0.000419	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CAV1—atherosclerosis	6.51e-05	0.000417	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APOA1—atherosclerosis	6.49e-05	0.000416	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—F2—atherosclerosis	6.46e-05	0.000414	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ESR1—atherosclerosis	6.27e-05	0.000402	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—F2—atherosclerosis	6.19e-05	0.000397	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CG—atherosclerosis	6.18e-05	0.000397	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CG—atherosclerosis	5.93e-05	0.00038	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAPK3—atherosclerosis	5.92e-05	0.00038	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—INS—atherosclerosis	5.85e-05	0.000375	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL2—atherosclerosis	5.76e-05	0.000369	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MAPK3—atherosclerosis	5.68e-05	0.000364	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IGF1—atherosclerosis	5.66e-05	0.000363	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—INS—atherosclerosis	5.61e-05	0.00036	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL2—atherosclerosis	5.52e-05	0.000354	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF1—atherosclerosis	5.43e-05	0.000348	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SERPINE1—atherosclerosis	5.37e-05	0.000345	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SERPINE1—atherosclerosis	5.15e-05	0.000331	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NOS3—atherosclerosis	5.13e-05	0.000329	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOS3—atherosclerosis	4.92e-05	0.000316	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCL8—atherosclerosis	4.55e-05	0.000292	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AKT1—atherosclerosis	4.4e-05	0.000282	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL8—atherosclerosis	4.36e-05	0.00028	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—atherosclerosis	4.33e-05	0.000278	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AKT1—atherosclerosis	4.22e-05	0.00027	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—atherosclerosis	4.15e-05	0.000266	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MMP9—atherosclerosis	4.12e-05	0.000264	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NFKB1—atherosclerosis	4.07e-05	0.000261	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK8—atherosclerosis	4e-05	0.000257	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AKT1—atherosclerosis	3.99e-05	0.000256	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MMP9—atherosclerosis	3.95e-05	0.000253	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NFKB1—atherosclerosis	3.91e-05	0.000251	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK8—atherosclerosis	3.84e-05	0.000246	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AKT1—atherosclerosis	3.83e-05	0.000246	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VEGFA—atherosclerosis	3.7e-05	0.000237	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—STAT3—atherosclerosis	3.66e-05	0.000235	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VEGFA—atherosclerosis	3.54e-05	0.000227	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—STAT3—atherosclerosis	3.51e-05	0.000225	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK3—atherosclerosis	3.5e-05	0.000224	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TGFB1—atherosclerosis	3.39e-05	0.000218	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK3—atherosclerosis	3.35e-05	0.000215	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TGFB1—atherosclerosis	3.25e-05	0.000209	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—atherosclerosis	2.56e-05	0.000164	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—atherosclerosis	2.45e-05	0.000157	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT1—atherosclerosis	2.36e-05	0.000151	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT1—atherosclerosis	2.26e-05	0.000145	CbGpPWpGaD
